
The Swiss Cancer Center - Leman (SCCL) is an alliance against cancer forged between several academic and clinical institutions: the University Hospital of Lausnne (CHUV), the University Hospitals of Geneva (HUG), the University of Lausanne, the University of Geneva and the Swiss Federal Institute of Technology Lausanne (EPFL), as well as privileged partners (see below).
This alliance brings together, under a united and regional identity, all the specialists involved in the path from bench to bedside.
Focusing their efforts on emerging fields within oncology, the partner institutions intend to develop innovative strategies such as immunotherapy and precision oncology to achieve personalized and predictive medical strategies that will ultimately revolutionize patient care.
The SCCL conducts its research in a network of laboratories located within its constituent institutions.
Executive committee
The SCCL Executive Committee is composed of the senior directors in oncology of its partner institutions:
* Professor
George Coukos, Head of the Department of oncology UNIL CHUV
* Professor
Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (ISREC) at EPFL
* Professor
Pierre-Yves Dietrich, Head of the Department of oncology HUG UNIGE
The AGORA building
The Agora, the flagship building of the Swiss Cancer Centre - Leman (SCCL), embodies and puts into the practice the central vision of the SCCL has for cancer science and medicine.
Other
In 2016, the
University Hospital of Lausanne
The Lausanne University Hospital (french: Centre hospitalier universitaire vaudois, CHUV), in Lausanne, is one of the five university hospitals in Switzerland.
The Lausanne University Hospital is linked to the Faculty of Biology and Medicine ...
inaugurated a cell production laboratory for
cancer immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease. It is an application of the fundamental research of cancer i ...
on the
Biopôle campus (
Épalinges
Épalinges (; frp, Epalinjo) is a municipality in the district of Lausanne in the canton of Vaud in Switzerland.
It is a suburb of the city of Lausanne.
History
Épalinges is first mentioned in 1182 as ''de Spanengis''.
Geography
Épalinges ...
).
[ Nathalie Jollien]
"Nouveau laboratoire d'immunothérapie à Lausanne"
''Le temps
''Le Temps'' (literally "The Time") is a Swiss French-language daily newspaper published in Berliner format in Geneva by Le Temps SA. It is the sole nationwide French-language non-specialised daily newspaper of Switzerland. Since 2021, it has ...
'', 15 September 2016 (page visited on 16 September 2016).
See also
*
Lausanne campus
The Lausanne campus or Dorigny university campus (French: ''campus lausannois'' or ''campus de Dorigny'') is a large area in Switzerland where the University of Lausanne (UNIL), the École polytechnique fédérale de Lausanne (EPFL) and several o ...
Notes and references
{{Portal bar, Biology, Medicine, Switzerland
Cancer organisations based in Switzerland